Nan Lin
- Molecular Biology
- Cancer Research top 10%
- Immunology
- Epidemiology
- Nephrology top 5%
- Topics
- Cancer, Hypoxia, and Metabolism (4 papers)Nanomaterials for catalytic reactions (3 papers)Asymmetric Hydrogenation and Catalysis (3 papers)
- Cited by
- Cancer ResearchNephrologyImmunology
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Nan Lin
24 papers receiving 933 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 443
- Cancer Research 265
- Immunology 196
- Epidemiology 112
- Nephrology 91
Countries citing papers authored by Nan Lin
This map shows the geographic impact of Nan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Lin more than expected).
Fields of papers citing papers by Nan Lin
This network shows the impact of papers produced by Nan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Lin. The network helps show where Nan Lin may publish in the future.
Co-authorship network of co-authors of Nan Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Nan Lin. A scholar is included among the top collaborators of Nan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Lin. Nan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 151 | |
| 5 | 69 | |
| 6 | 42 | |
| 7 | 23 | |
| 8 | 1 | |
| 9 | 14 | |
| 10 | 86 | |
| 11 | 29 | |
| 12 | 27 | |
| 13 | 122 | |
| 14 | 118 | |
| 15 | 41 | |
| 16 | 4 | |
| 17 | 101 | |
| 18 | 1 | |
| 19 | 23 | |
| 20 | 5 |
About Nan Lin
Nan Lin is a scholar working on Cancer Research, Immunology and Biochemistry, having authored 24 papers that have together received 943 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Nanomaterials for catalytic reactions (3 papers) and Asymmetric Hydrogenation and Catalysis (3 papers). The work is most often cited by research in Cancer Research (265 citations), Nephrology (91 citations) and Immunology (196 citations). Nan Lin has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include M. Celeste Simon, Lina Zhang, Changyong Zhou, Mei Zhang, Peng Li, Wei Deng, Zi‐Jian Yao, Brian Keith, Pearl Lee and Ian A. Blair. Their work appears in journals such as Journal of Clinical Investigation, Genes & Development and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.